Lab stops abortive sales in France due to side effects

Cytotec, consisting of misoprostol, began to be marketed in France in 1987 for the preventive and curative treatment of ulcers.

The Pfizer laboratory will no longer sell in France, as of March 1, 2018, a drug used to induce labor, Cytotec, due to the health warnings it has raised, the National Agency for Medicinal Product Safety said on Friday. Health Products (ANSM) in the European country.

The laboratory decision is due to the health warnings issued by the ANSM, which pointed out that Cytotec can cause serious side effects for both the parturient (rupture of the uterine muscle) and in the fetus, with hemorrhages and heartbeat abnormalities.

Related image

Cytotec, consisting of misoprostol, began to be marketed in France in 1987 for the preventive and curative treatment of steroid-induced ulcers and gastroduodenal lesions, but its use is increasingly residual due to the commercialization of other products.

Despite warnings from the French agency, the drug was used in France to induce deliveries from 37 weeks of amenorrhea and for voluntary terminations of pregnancy.

Related image

In Brazil, where abortion is considered a crime, Cytotec has been illegally marketed over the internet for many years and its sale is banned by the National Sanitary Surveillance Agency (Anvisa).

Currently, any sale of drugs based on the substance misoprostol, which is part of the list of substances subject to special control regularly updated by Anvisa, is restricted to duly registered and accredited hospitals.

Shares